FdaApplication
NDA 020151
Identifiers
- fda_app_no: NDA020151
Properties
| Property | Value |
|---|---|
| applicant_name | WYETH PHARMACEUTICALS INC |
| application_type | NDA |
| approval_date | 1993-12-28 |
Products (6)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| EFFEXOR | VENLAFAXINE HYDROCHLORIDE | EQ 12.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET;ORAL |
| EFFEXOR | VENLAFAXINE HYDROCHLORIDE | EQ 100MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET;ORAL |
| EFFEXOR | VENLAFAXINE HYDROCHLORIDE | EQ 50MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET;ORAL |
| EFFEXOR | VENLAFAXINE HYDROCHLORIDE | EQ 75MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET;ORAL |
| EFFEXOR | VENLAFAXINE HYDROCHLORIDE | EQ 25MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET;ORAL |
| EFFEXOR | VENLAFAXINE HYDROCHLORIDE | EQ 37.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET;ORAL |
6 products